dc.contributor.author |
Gichangi, P. |
|
dc.contributor.author |
Vuyst, H. De |
|
dc.contributor.author |
Estambale, Benson B. |
|
dc.contributor.author |
Rogo, K. |
|
dc.contributor.author |
Bwayo, J. |
|
dc.contributor.author |
Temmerman, M. |
|
dc.date.accessioned |
2018-06-25T13:07:29Z |
|
dc.date.available |
2018-06-25T13:07:29Z |
|
dc.date.issued |
2002-01-22 |
|
dc.identifier.uri |
https://obgyn.onlinelibrary.wiley.com/doi/full/10.1016/S0020-7292%2801%2900560-4# |
|
dc.identifier.uri |
https://doi.org/10.1016/S0020-7292(01)00560-4 |
|
dc.identifier.uri |
http://ir.jooust.ac.ke:8080/xmlui/handle/123456789/1326 |
|
dc.description |
https://doi.org/10.1016/S0020-7292(01)00560-4 |
en_US |
dc.description.abstract |
To determine the effect of the HIV epidemic on invasive cervical cancer in Kenya. Methods: Of the 3902 women who were diagnosed with reproductive tract malignancies at Kenyatta National Hospital (KNH) from 1989 to 1998, 85% had invasive cervical cancer. Age at presentation and severity of cervical cancer were studied for a 9‐year period when national HIV prevalence went from 5% to 5–10%, to 10–15%. Results:There was no significant change in either age at presentation or severity of cervical cancer. Of the 118 (5%) women who were tested for HIV, 36 (31%) were seropositive. These women were 5 years younger at presentation than HIV‐negative women. Conclusions: A two‐ to three‐fold increase in HIV prevalence in Kenya did not seem to have a proportional effect on the incidence of cervical cancer. Yet, HIV‐positive women who presented with cervical cancer were significantly younger than HIV‐negative women. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
International Journal of Gynecology & Obstetrics |
en_US |
dc.subject |
HIV |
en_US |
dc.subject |
Cervical cancer |
en_US |
dc.subject |
Kenya |
en_US |
dc.title |
HIV and cervical cancer in Kenya |
en_US |
dc.type |
Article |
en_US |